thalidomide has been researched along with Hemangioma in 7 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Hemangioma: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemangiomas are benign neoplasms of the vasculature frequently encountered in children." | 2.47 | Hemangiomas - current therapeutic strategies. ( Mabeta, P; Pepper, MS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Khurana, A | 1 |
| Savitha, B | 1 |
| Adam, Z | 1 |
| Pour, L | 1 |
| Krejcí, M | 1 |
| Pourová, E | 1 |
| Synek, O | 1 |
| Zahradová, L | 1 |
| Navrátil, M | 1 |
| Mechl, M | 1 |
| Nebeský, T | 1 |
| Neubauer, J | 1 |
| Feit, J | 1 |
| Vokurková, J | 1 |
| Král, Z | 1 |
| Bednarík, O | 1 |
| Slampa, P | 1 |
| Dolezalová, H | 1 |
| Hájek, R | 1 |
| Mayer, J | 1 |
| Mabeta, P | 1 |
| Pepper, MS | 1 |
| Lindner, DJ | 1 |
| Jarvi, K | 1 |
| Roebuck, DJ | 1 |
| Sebire, NJ | 1 |
| Lindley, K | 1 |
| Shah, N | 1 |
| Salomon, J | 1 |
| Curry, JI | 1 |
| Roe, FJ | 1 |
| Walters, MA | 1 |
| Kida, M | 1 |
| Lenz, W | 1 |
3 reviews available for thalidomide and Hemangioma
| Article | Year |
|---|---|
[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
Topics: Adult; Aged; Angiogenesis Inhibitors; Angiomatosis; Female; Hemangioma; Humans; Interferon-alpha; Ma | 2010 |
Hemangiomas - current therapeutic strategies.
Topics: Angiogenesis Inhibitors; Bleomycin; Child; Cyclophosphamide; Hemangioma; Humans; Interferons; Neovas | 2011 |
Interferons as antiangiogenic agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Syne | 2002 |
4 other studies available for thalidomide and Hemangioma
| Article | Year |
|---|---|
Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Head; Hemangioma; Humans; Rare Diseases; Thalidomide | 2022 |
Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog.
Topics: Angiogenesis Inhibitors; Female; Hemangioma; Humans; Infant; Intestinal Neoplasms; Somatostatin; Tha | 2008 |
Sensitivity of newborn mice to carcinogenic agents.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepa | 1968 |
[Thalidomide embryopathy in Japan].
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Ear; Ectromelia; Female; Fetal Diseases; Finge | 1968 |